InvestorsHub Logo
icon url

Awlau

11/27/19 11:35 AM

#9606 RE: CoolG73 #9605

Cool, did management ever comment in any CC about AURORA 2? How the recruitment was. Easy? Hard? Over-recruited?
icon url

Watsonturtle

11/27/19 1:02 PM

#9613 RE: CoolG73 #9605

Thanks for the Feedback. I like the quote: "in proving that this drug is really something ..." It's good to know "really something"is a positive comment ... My spouse from time to time says that I am "really something". So I got that going for me! :)

Happy thanksgiving,

WT
icon url

Watsonturtle

12/02/19 5:12 PM

#9649 RE: CoolG73 #9605

Cool,

Question regarding Aurora 2 trial:

Here is what I understand:

- that Aurora 2 is a continuation of Aurora 1 for an additional 24 months (with patients from Aurora 1 rolling over into Aurora 2) with the the purpose being "to assess the long-term safety and tolerability of voclosporin, added to the standard of care treatment in LN, for an additional 24 months".


Here is my question:

Is this a blinded study? (apologize if this is a dumb question). I would assume that it is not ... i.e., that they know who the patients are, and that AUPH will provide updates on the status of this trial each Q.

The reason I ask is that the study will not be completed until 2021 ... that's a long ways out ...

WT